19-41018182-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000767.5(CYP2B6):​c.*1355A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.683 in 151,970 control chromosomes in the GnomAD database, including 36,107 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 36107 hom., cov: 31)
Exomes 𝑓: 0.90 ( 21 hom. )
Failed GnomAD Quality Control

Consequence

CYP2B6
NM_000767.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.246

Publications

27 publications found
Variant links:
Genes affected
CYP2B6 (HGNC:2615): (cytochrome P450 family 2 subfamily B member 6) This gene, CYP2B6, encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by phenobarbital. The enzyme is known to metabolize some xenobiotics, such as the anti-cancer drugs cyclophosphamide and ifosphamide. Transcript variants for this gene have been described; however, it has not been resolved whether these transcripts are in fact produced by this gene or by a closely related pseudogene, CYP2B7. Both the gene and the pseudogene are located in the middle of a CYP2A pseudogene found in a large cluster of cytochrome P450 genes from the CYP2A, CYP2B and CYP2F subfamilies on chromosome 19q. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.78 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP2B6NM_000767.5 linkc.*1355A>G 3_prime_UTR_variant Exon 9 of 9 ENST00000324071.10 NP_000758.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP2B6ENST00000324071.10 linkc.*1355A>G 3_prime_UTR_variant Exon 9 of 9 1 NM_000767.5 ENSP00000324648.2

Frequencies

GnomAD3 genomes
AF:
0.683
AC:
103731
AN:
151852
Hom.:
36079
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.788
Gnomad AMI
AF:
0.563
Gnomad AMR
AF:
0.784
Gnomad ASJ
AF:
0.693
Gnomad EAS
AF:
0.663
Gnomad SAS
AF:
0.781
Gnomad FIN
AF:
0.598
Gnomad MID
AF:
0.803
Gnomad NFE
AF:
0.605
Gnomad OTH
AF:
0.701
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.896
AC:
43
AN:
48
Hom.:
21
Cov.:
0
AF XY:
0.833
AC XY:
20
AN XY:
24
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
1.00
AC:
2
AN:
2
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
1.00
AC:
28
AN:
28
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.722
AC:
13
AN:
18
Other (OTH)
AC:
0
AN:
0
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.683
AC:
103809
AN:
151970
Hom.:
36107
Cov.:
31
AF XY:
0.688
AC XY:
51109
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.788
AC:
32647
AN:
41456
American (AMR)
AF:
0.784
AC:
11972
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.693
AC:
2405
AN:
3468
East Asian (EAS)
AF:
0.663
AC:
3427
AN:
5170
South Asian (SAS)
AF:
0.779
AC:
3747
AN:
4810
European-Finnish (FIN)
AF:
0.598
AC:
6299
AN:
10526
Middle Eastern (MID)
AF:
0.808
AC:
236
AN:
292
European-Non Finnish (NFE)
AF:
0.605
AC:
41082
AN:
67956
Other (OTH)
AF:
0.702
AC:
1482
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1671
3343
5014
6686
8357
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
816
1632
2448
3264
4080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.630
Hom.:
74215
Bravo
AF:
0.698
Asia WGS
AF:
0.721
AC:
2506
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.2
DANN
Benign
0.46
PhyloP100
-0.25
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs707265; hg19: chr19-41524087; API